cas 1454847-96-1|| where to buy (1S)-1-(5-fluoro-2-iodophenyl)ethanol

Product Name:(1S)-1-(5-fluoro-2-iodophenyl)ethanol

IUPAC Name:(1S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol

: CAS：1454847-96-1; Molecular Formula：C8H8FIO; Purity：95%+

: Catalog Number：CM336652; Molecular Weight：266.05

Packing Unit	Available Stock	Price($)
CM336652-5g	in stock	Ĳƥ
CM336652-10g	in stock	ŤǙƿ
CM336652-25g	in stock	ƈƿǙ

Inquiry: sales@chemenu.com

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1454847-96-1 regularly via the above email.

Additional Notes

Verification code*

refresh

Product Details

: CAS NO:1454847-96-1; Molecular Formula:C8H8FIO; Melting Point:-; Smiles Code:C[C@H](O)C1=CC(F)=CC=C1I; Density:

: Catalog Number:CM336652; Molecular Weight:266.05; Boiling Point:; MDL No:; Storage:

Category Infos

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

: Benzenes

: Lorlatinib; Pfizer announced longer-term follow-up results of the Phase 3 CROWN study at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. This study aims to evaluate the efficacy and safety of the third-generation anaplastic lymphoma kinase (ALK) inhibitor LORBRENA® (lorlatinib, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). The analysis showed that compared with the first-generation ALK inhibitors, the risk of disease progression or death in patients treated with lorlatinib continued to decrease by 81%, and the risk of brain metastasis progression was reduced by 94%.

Related Products

2176-45-6

7356-11-8

5471-82-9

7697-28-1

148547-19-7

24078-21-5

59382-59-1

15068-35-6

1975-52-6

7697-26-9

4837-88-1

1975-50-4

5437-38-7

96-98-0

939-80-0

456-04-2

69272-50-0

77811-44-0

19694-10-1

622-52-6

99548-54-6

6967-82-4

7463-51-6

94695-48-4

2106-49-2

537013-51-7

66416-72-6

1460-02-2

658-93-5

67515-55-3

314-46-5

450-88-4

345226-19-9

63435-16-5

403-20-3

37466-90-3

86256-59-9

196081-71-7

253120-47-7

349-55-3

85462-59-5

456-14-4

71643-66-8

329-78-2

22996-21-0

41085-43-2

17610-00-3

38980-96-0

2314-36-5

453-71-4

200190-87-0

57486-69-8

77324-87-9

5162-82-3

74597-04-9

17841-69-9

28165-52-8

30186-18-6

16554-45-3

33890-03-8

53984-36-4

265670-72-2

63059-25-6

16583-08-7

10385-30-5

71924-62-4

41052-75-9

51719-65-4

2713-28-2

133921-27-4

636-94-2

24078-12-4

1835-02-5

1000339-51-4

147808-42-2

943-27-1

180636-50-4

28165-49-3

42113-13-3

38936-60-6

1575-36-6

7138-15-0

123843-67-4

156001-68-2

6942-39-8

1643-29-4

536-25-4

4385-76-6

7766-23-6

379228-57-6

935-99-9

886762-70-5

369-26-6

53631-18-8

849758-12-9

34633-69-7

876-33-5

773873-72-6

6232-11-7

1991-87-3

267225-27-4

5557-83-5

6404-31-5

62561-74-4

33769-07-2

20949-81-9

24589-99-9

886762-71-6

112671-42-8

50670-49-0

74733-29-2

586374-04-1

56525-63-4

176694-36-3

402955-41-3

522651-48-5

50-45-3

102169-44-8

52427-05-1

79669-49-1

36138-76-8

22532-62-3

1666-28-0

53663-39-1

76006-33-2

7697-29-2

55289-36-6

606-18-8

528-45-0

6705-03-9

403-21-4

59557-92-5

7693-46-1

6627-53-8

3177-80-8

394-01-4

88744-36-9

37148-48-4

59443-15-1

77527-00-5

83507-33-9

117338-43-9

189628-37-3

1761-61-1

25016-01-7

708-76-9

41489-76-3

5395-89-1

55512-05-5

10040-98-9

27913-99-1

87626-41-3

33016-47-6

53066-19-6

756520-66-8

900175-01-1

1141669-81-9

124980-94-5

330156-50-8

877397-65-4

202865-66-5

697306-45-9

864265-08-7

51503-08-3

60211-57-6

229027-89-8

216755-56-5

79538-03-7

39945-51-2

19444-23-6

188582-62-9

149104-89-2

52244-70-9

153203-58-8

367519-84-4

1823942-84-2

1823900-28-2

1823900-94-2

1820712-30-8

1820705-12-1

1333114-86-5

1021871-35-1

20712-12-3

123986-64-1

96449-69-3

70448-03-2

261723-32-4

83647-43-2

168886-97-3

1232407-29-2

120077-68-1

163190-79-2

35364-79-5

648439-19-4

96145-98-1

1824057-69-3

133662-20-1

77771-03-0

100306-33-0

160647-01-8

60666-70-8

81156-68-5

329218-12-4

34743-88-9

20570-96-1

58971-11-2

107622-80-0

2905-24-0

1975-51-5

393-06-6

93102-05-7

64695-96-1

372-16-7

502496-33-5

54962-75-3

58458-10-9

402-14-2

46004-37-9

6952-59-6

2042-37-7

67567-26-4

1073-70-7

79422-73-4

20587-30-8

77171-41-6

105181-72-4

62023-65-8

116661-86-0

62023-63-6

133082-13-0